Home QuantaMatrix

QuantaMatrix

In operation
IPO
In Vitro Diagnostics Product Developer

Basic Information

QuantaMatrix provides a solution that significantly reduces the screening time for diagnosing sepsis and tuberculosis through patented microfluidic agarose channel technology and time-lapse microscopy imaging analysis technology, which requires rapid and accurate antimicrobial prescribing. A rapid antimicrobial susceptibility testing system can accelerate patient treatment through early and optimal prescribing, reduce mortality from sepsis/bacteremia, and help prevent antibiotic abuse and the spread of antimicrobial resistance.
QuantaMatrix Inc.
Seoul,SeoulSpecialCity,SouthKorea
51~100 people
January 01, 2010
contact@quantamatrix.com